LIQUID BIOSCIENCES Trademark

Trademark Overview

On Monday, March 27, 2017, a trademark application was filed for LIQUID BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the LIQUID BIOSCIENCES trademark a serial number of 87386620. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 11, 2025. This trademark is owned by Liquid Biosciences, Inc.. The LIQUID BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Computer modeling services in the nature of bioanalytical testing services in the field of modeling biological systems for the purposes of medical intervention; computer modeling consulting services in the field of biomarker discovery, method development, validation and reporting for the purposes of medical intervention; computer modeling research and development services in the field of biomarker and clinical target development for the purposes of medical intervention
liquid biosciences

General Information

Serial Number87386620
Word MarkLIQUID BIOSCIENCES
Filing DateMonday, March 27, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 11, 2025
Registration Number5645531
Registration DateTuesday, January 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesComputer modeling services in the nature of bioanalytical testing services in the field of modeling biological systems for the purposes of medical intervention; computer modeling consulting services in the field of biomarker discovery, method development, validation and reporting for the purposes of medical intervention; computer modeling research and development services in the field of biomarker and clinical target development for the purposes of medical intervention

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, July 12, 2025
Primary Code042
First Use Anywhere DateWednesday, January 31, 2018
First Use In Commerce DateThursday, May 31, 2018

Trademark Owner History

Party NameLiquid Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656
Party NameLiquid Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2017NON-FINAL ACTION WRITTEN
Thursday, March 30, 2017NEW APPLICATION ENTERED
Thursday, March 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 20, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2017NON-FINAL ACTION E-MAILED
Friday, June 23, 2017UNDELIVERABLE MAIL - COURTESY COPY MAILED
Friday, December 1, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 12, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 1, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2017ASSIGNED TO LIE
Tuesday, December 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 20, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2017NON-FINAL ACTION E-MAILED
Monday, March 5, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, March 5, 2018WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, July 18, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 18, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 6, 2018TEAS PETITION TO REVIVE RECEIVED
Thursday, September 6, 2018PETITION TO REVIVE-GRANTED
Thursday, September 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 7, 2018NOTICE OF REVIVAL - MAILED
Monday, September 17, 2018ASSIGNED TO LIE
Tuesday, September 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 14, 2018NON-FINAL ACTION WRITTEN
Sunday, October 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 14, 2018NON-FINAL ACTION E-MAILED
Thursday, November 1, 2018TEAS AMENDMENT OF USE RECEIVED
Thursday, November 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 1, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 2, 2018AMENDMENT TO USE PROCESSING COMPLETE
Friday, November 2, 2018USE AMENDMENT FILED
Friday, November 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 13, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Saturday, November 3, 2018USE AMENDMENT ACCEPTED
Tuesday, November 6, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, November 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, November 12, 2018EXAMINERS AMENDMENT E-MAILED
Monday, November 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 13, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, January 1, 2019REGISTERED-SUPPLEMENTAL REGISTER
Thursday, November 29, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 11, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 11, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

biosciences liquid modeling services computer intervention development purposes medical field biomarker validation